Arjun Goyal
Director at Centessa Pharmaceuticals plc (CNTA)
Arjun Goyal has filed 6 insider reports with the SEC since July 2022, as director at Centessa Pharmaceuticals plc (CNTA). Arjun Goyal made no open-market purchases or sales in the last 12 months. The latest filing, on June 24, 2026, reports sale back to the company at Centessa Pharmaceuticals plc (CNTA).
- Filings
- 6
- Companies
- 1
- Bought on market
- $5.87M
- Sold on market
- None
Companies where Arjun Goyal is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | $5.87M | $12.68 | Jun 24, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 24, 2026CNTADirector Goyal Arjun returned 462,585 units of Ordinary Shares to the company (tax liability)Form 4Sale back to the company
- Jun 20, 2025CNTASEC Form 4 filed by Director Goyal ArjunForm 4Grant or award
- May 16, 2025+$5.87MCNTADirector Goyal Arjun bought $5,865,242 worth of Ordinary Shares (462,585 units at $12.68)Form 4Open-market purchase
- Jun 25, 2024CNTASEC Form 4 filed by Director Goyal ArjunForm 4Grant or award
- Jun 22, 2023CNTASEC Form 4 filed by Goyal ArjunForm 4Grant or award
- Jun 30, 2022CNTASEC Form 4 filed by Goyal ArjunForm 4Grant or award
Compare Arjun Goyal with
- Arjun Goyal vs Tia L Bush1 shared
- Arjun Goyal vs Iqbal J Hussain1 shared
- Arjun Goyal vs Karen M. Anderson1 shared
- Arjun Goyal vs John J Crowley1 shared
- Arjun Goyal vs Raphael Deferiere1 shared
- Arjun Goyal vs Francesco De Rubertis1 shared
Other insiders at the same companies
- Medicxi Ventures Management (Jersey) LtdCNTA
- Index Ventures Life Vi (jersey) L.P.CNTA
- Tia L BushCNTA
- Iqbal J HussainCNTA
- Karen M. AndersonCNTA
- John J CrowleyCNTA
- Raphael DeferiereCNTA
- Francesco De RubertisCNTA
- Stephen KanesCNTA
- Mario Alberto AccardiCNTA
- Mary Lynne HedleyCNTA
- Zbar Brett I WCNTA
- Carol StuckleyCNTA
- Samarth KulkarniCNTA
- Mathias HukkelhovenCNTA
- Gregory M WeinhoffCNTA
Questions about Arjun Goyal
- What is Arjun Goyal's role at Centessa Pharmaceuticals plc?
- Arjun Goyal reports to the SEC as director at Centessa Pharmaceuticals plc (CNTA), according to the latest filing on June 24, 2026.
- Has Arjun Goyal bought or sold stock recently?
- The most recent open-market purchase was on May 16, 2025: bought 462,585 shares of Centessa Pharmaceuticals plc (CNTA) for $5.87M at an average of $12.68.
- How do I get alerts when Arjun Goyal files?
- Follow Arjun Goyal on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Arjun Goyal (SEC CIK 0001861844). Totals count each trade once, skipping amendments whose original is on file, from Jul 5, 2022 on. View on SEC EDGAR · Get this as JSON